Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on Sotatercept for Children with Pulmonary Arterial Hypertension Receiving Standard Care

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany The Netherlands Poland Spain
  • Vasopressin Versus Norepinephrine for Patients with Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Endarterectomy Surgery

    Not yet recruiting

    3 1 1 1
    France
  • A study to evaluate the safety and effectiveness of IKT-001 compared to a placebo in adults with pulmonary arterial hypertension.

    Not yet recruiting

    4 1
    Belgium Czechia Denmark France Germany Greece +8
  • Study of gallium-68 FAPI imaging to assess blood vessel changes in patients with pulmonary arterial hypertension receiving sotatercept

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    France
  • Study of calcifediol treatment to improve vitamin D levels in adults with pulmonary arterial hypertension

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    Spain
  • Study of Empagliflozin to Improve Heart Function in Adults with Pulmonary Arterial Hypertension

    Not yet recruiting

    2 1
    Investigated Drugs:
    Germany
  • Study on Macitentan for Children with Pulmonary Arterial Hypertension

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Hungary Poland Portugal Spain
  • Study on the Safety and Tolerability of Sotatercept for Patients with Pulmonary Arterial Hypertension

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia France Hungary Italy The Netherlands Poland +1
  • Study of Sotatercept for People with Pulmonary Arterial Hypertension

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia France Germany Hungary Italy The Netherlands +2
  • Study Comparing the Effectiveness and Safety of Macitentan 75 mg and 10 mg for Patients with Pulmonary Arterial Hypertension

    Not recruiting

    3 1 1
    Investigated Drugs:
    Austria Belgium Bulgaria Czechia Denmark France +10